Yves Leblond
Technik-/Wissenschafts-/F&E-Leiter bei AzurRx BioPharma SAS
Profil
Yves Leblond is a Director of Research and Development at AzurRx BioPharma SAS since 2009.
Prior to this, he held the same position at First Wave Biopharma, Inc. and LMS Laboratories.
He was also the Head of the Non-Clinical Drug Safety Department at Fournier Group, Inc. from 1991 to 2002.
In addition, he was the Head of the Preclinical Department at Boehringer Laboratories LLC from 1984 to 1986.
Dr. Leblond holds a doctorate degree from Université de Paris XI Paris Sud.
Aktive Positionen von Yves Leblond
| Unternehmen | Position | Beginn |
|---|---|---|
AzurRx BioPharma SAS
 AzurRx BioPharma SAS Miscellaneous Commercial ServicesCommercial Services Part of First Wave Biopharma, Inc., AzurRx BioPharma SAS is a French company that provides bioscience and biotechnology research and development services. The company is based in Langlade, France. AzurRx BioPharma was acquired by First Wave Biopharma, Inc. from Protea Biosciences Group, Inc. on June 13, 2014 for $2.20 million. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2009 |
Ehemalige bekannte Positionen von Yves Leblond
| Unternehmen | Position | Ende |
|---|---|---|
| LMS Laboratories | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2009 |
Fournier Group, Inc.
 Fournier Group, Inc. Multi-Line InsuranceFinance Part of RSC Insurance Brokerage, Inc., Fournier Group, Inc. is a dynamic independent insurance agency headquartered in Portland, OR. Fournier Group, Inc. provides personal (home/auto/specialty), business, and aviation insurance to diverse clients. The company was founded by Dirk Fournier. Fournier Group was acquired by RSC Insurance Brokerage, Inc. on December 09, 2021. | Corporate Officer/Principal | 01.01.2002 |
Boehringer Laboratories LLC
 Boehringer Laboratories LLC Medical SpecialtiesHealth Technology Boehringer Laboratories LLC manufactures medical instruments. The company was founded by Jack R. Boehringer in 1972 and is headquartered in Norristown, PA. | Corporate Officer/Principal | 01.01.1986 |
| ENTERO THERAPEUTICS, INC. | Corporate Officer/Principal | - |
Ausbildung von Yves Leblond
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ENTERO THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 5 |
|---|---|
| Université de Paris XI Paris Sud | Consumer Services |
AzurRx BioPharma SAS
AzurRx BioPharma SAS Miscellaneous Commercial ServicesCommercial Services Part of First Wave Biopharma, Inc., AzurRx BioPharma SAS is a French company that provides bioscience and biotechnology research and development services. The company is based in Langlade, France. AzurRx BioPharma was acquired by First Wave Biopharma, Inc. from Protea Biosciences Group, Inc. on June 13, 2014 for $2.20 million. | Commercial Services |
| LMS Laboratories | |
Fournier Group, Inc.
Fournier Group, Inc. Multi-Line InsuranceFinance Part of RSC Insurance Brokerage, Inc., Fournier Group, Inc. is a dynamic independent insurance agency headquartered in Portland, OR. Fournier Group, Inc. provides personal (home/auto/specialty), business, and aviation insurance to diverse clients. The company was founded by Dirk Fournier. Fournier Group was acquired by RSC Insurance Brokerage, Inc. on December 09, 2021. | Finance |
Boehringer Laboratories LLC
Boehringer Laboratories LLC Medical SpecialtiesHealth Technology Boehringer Laboratories LLC manufactures medical instruments. The company was founded by Jack R. Boehringer in 1972 and is headquartered in Norristown, PA. | Health Technology |
